The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

One study found that seven years postoperation, most patients had maintained weight loss, and high cholesterol, high blood ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.